| 臺大學術典藏 |
2022-06-27T06:59:40Z |
Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan
|
Chen Y.-M.; Chih-Hsin Yang J.; Su W.-C.; Chong I.-W.; Hsia T.-C.; Lin M.-C.; Chang G.-C.; Chiu C.-H.; Ho C.-C.; Wu S.-Y.; Hung J.-Y.; Wang C.-C.; Yang T.-Y.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-06-27T06:59:37Z |
Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in Asia
|
Blechter B.; Wong J.Y.Y.; Agnes Hsiung C.; Hosgood H.D.; Yin Z.; Shu X.-O.; Zhang H.; Shi J.; Song L.; Song M.; Zheng W.; Wang Z.; Caporaso N.; Burdette L.; Yeager M.; Berndt S.I.; Teresa Landi M.; Chen C.-J.; Chang G.-C.; Hsiao C.-F.; Tsai Y.-H.; Chen K.-Y.; Huang M.-S.; Su W.-C.; Chen Y.-M.; Chien L.-H.; Chen C.-H.; Yang T.-Y.; Wang C.-L.; Hung J.-Y.; Lin C.-C.; Perng R.-P.; Chen C.-Y.; Chen K.-C.; Li Y.-J.; CHONG-JEN YU; Chen Y.-S.; Chen Y.-H.; Tsai F.-Y.; Jie Seow W.; Bassig B.A.; Hu W.; Ji B.-T.; Wu W.; Guan P.; He Q.; Gao Y.-T.; Cai Q.; Chow W.-H.; Xiang Y.-B.; Lin D.; Wu C.; Wu Y.-L.; Shin M.-H.; Hong Y.-C.; Matsuo K.; Chen K.; Pik Wong M.; Lu D.; Jin L.; Wang J.-C.; Seow A.; Wu T.; Shen H.; Fraumeni J.F.; Yang P.-C.; Chang I.-S.; Zhou B.; Chanock S.J.; Rothman N.; Chatterjee N.; Lan Q. |
| 臺大學術典藏 |
2022-06-27T02:49:08Z |
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG)
|
Popat S.; Hsia T.-C.; Hung J.-Y.; Jung H.A.; JIN-YUAN SHIH; Park C.K.; Lee S.H.; Okamoto T.; Ahn H.K.; Lee Y.C.; Sato Y.; Lee S.S.; Mascaux C.; Daoud H.; M?rten A.; Miura S. |
| 臺大學術典藏 |
2022-05-10T08:09:40Z |
Systematic review and network meta-analysis of immune checkpoint inhibitors in combination with chemotherapy as a first-line therapy for extensive-stage small cell carcinoma
|
Chen H.-L.; YU-KANG TU; Chang H.-M.; Lee T.-H.; Wu K.-L.; Tsai Y.-C.; Lee M.-H.; Yang C.-J.; Hung J.-Y.; Chong I.-W. |
| 臺大學術典藏 |
2022-05-10T08:09:34Z |
Systematic review and network meta-analysis of anaplastic lymphoma kinase (Alk) inhibitors for treatment-na?ve alk-positive lung cancer
|
Chuang C.-H.; Chen H.-L.; Chang H.-M.; Tsai Y.-C.; Wu K.-L.; Chen I.-H.; Chen K.-C.; Lee J.-Y.; Chang Y.-C.; Chen C.-L.; YU-KANG TU; Hung J.-Y.; Yang C.-J.; Chong I.-W. |
| 臺大學術典藏 |
2022-05-10T08:09:28Z |
First-line anaplastic lymphoma kinase (Alk) inhibitors for alk-positive lung cancer in asian populations: Systematic review and network meta-analysis
|
Wu K.-L.; Chen H.-L.; Tsai Y.-M.; Lee T.-H.; Chang H.-M.; Tsai Y.-C.; Chuang C.-H.; Chang Y.-C.; YU-KANG TU; Yang C.-J.; Hung J.-Y.; Chong I.-W. |
| 臺大學術典藏 |
2022-05-10T08:09:25Z |
Salvage therapy for relapsed malignant pleural mesothelioma: A systematic review and network meta-analysis
|
Tsai Y.-C.; Chen H.-L.; Lee T.-H.; Chang H.-M.; Wu K.-L.; Chuang C.-H.; Chang Y.-C.; YU-KANG TU; Hung J.-Y.; Yang C.-J.; Chong I.-W. |
| 國立成功大學 |
2022 |
An Outperforming Artificial Intelligence Model to Identify Referable Blepharoptosis for General Practitioners
|
Hung, J.-Y.;Chen, K.-W.;Perera, C.;Chiu, H.-K.;Hsu, C.-R.;Myung, D.;Luo, A.-C.;Fuh, C.-S.;Liao, S.-L.;Kossler, A.L. |
| 臺大學術典藏 |
2021-11-03T02:32:59Z |
Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencing
|
Lin Y.-T.; Chiang C.-L.; Hung J.-Y.; Lee M.-H.; Su W.-C.; Wu S.-Y.; Wei Y.-F.; Lee K.-Y.; Tseng Y.-H.; Su J.; Chung H.-P.; Lin C.-B.; Ku W.-H.; Chiang T.-S.; Chiu C.-H.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-09-04T03:10:17Z |
Survival outcomes of eye-sparing surgery for adenoid cystic carcinoma of lacrimal gland
|
Hung J.-Y.; Wei Y.-H.; Huang C.-H.; Chen L.-W.; Fuh C.-S.; SHU-LANG LIAO |
